These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
429 related articles for article (PubMed ID: 30103114)
1. miR-23c suppresses tumor growth of human hepatocellular carcinoma by attenuating ERBB2IP. Zhang L; Wang Y; Wang L; Yin G; Li W; Xian Y; Yang W; Liu Q Biomed Pharmacother; 2018 Nov; 107():424-432. PubMed ID: 30103114 [TBL] [Abstract][Full Text] [Related]
2. LncRNA KTN1-AS1 promotes tumor growth of hepatocellular carcinoma by targeting miR-23c/ERBB2IP axis. Zhang L; Wang L; Wang Y; Chen T; Liu R; Yang W; Liu Q; Tu K Biomed Pharmacother; 2019 Jan; 109():1140-1147. PubMed ID: 30551364 [TBL] [Abstract][Full Text] [Related]
3. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein. Chen S; Wang L; Yao B; Liu Q; Guo C Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4. Guo Y; Yao B; Zhu Q; Xiao Z; Hu L; Liu X; Li L; Wang J; Xu Q; Yang L; Huang D J Cell Mol Med; 2019 Aug; 23(8):5037-5047. PubMed ID: 31207037 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase. Fei X; Zhang P; Pan Y; Liu Y Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170 [TBL] [Abstract][Full Text] [Related]
6. LncRNA ZEB1-AS1 regulates hepatocellular carcinoma progression by targeting miR-23c. Xue S; Lu F; Sun C; Zhao J; Zhen H; Li X World J Surg Oncol; 2021 Apr; 19(1):121. PubMed ID: 33865414 [TBL] [Abstract][Full Text] [Related]
7. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis. Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188 [TBL] [Abstract][Full Text] [Related]
8. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway. Bao J; Chen X; Hou Y; Kang G; Li Q; Xu Y Biomed Pharmacother; 2018 Nov; 107():824-833. PubMed ID: 30142544 [TBL] [Abstract][Full Text] [Related]
9. LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4. Yang X; Sun L; Wang L; Yao B; Mo H; Yang W Biomed Pharmacother; 2019 Oct; 118():109386. PubMed ID: 31545291 [TBL] [Abstract][Full Text] [Related]
10. MiR-3174 promotes proliferation and inhibits apoptosis by targeting FOXO1 in hepatocellular carcinoma. Wang Q; Yang X; Zhou X; Wu B; Zhu D; Jia W; Chu J; Wang J; Wu J; Kong L Biochem Biophys Res Commun; 2020 Jun; 526(4):889-897. PubMed ID: 32279994 [TBL] [Abstract][Full Text] [Related]
11. MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma. Huang GH; Shan H; Li D; Zhou B; Pang PF Cell Biochem Funct; 2017 Mar; 35(2):98-104. PubMed ID: 28261837 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-769-5p contributes to the proliferation, migration and invasion of hepatocellular carcinoma cells by attenuating RYBP. Xian Y; Wang L; Yao B; Yang W; Mo H; Zhang L; Tu K Biomed Pharmacother; 2019 Oct; 118():109343. PubMed ID: 31545279 [TBL] [Abstract][Full Text] [Related]
13. miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma. Zhang C; Chen B; Jiao A; Li F; Sun N; Zhang G; Zhang J BMC Cancer; 2018 Nov; 18(1):1179. PubMed ID: 30486878 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-150 suppresses cell proliferation and metastasis in hepatocellular carcinoma by inhibiting the GAB1-ERK axis. Sun W; Zhang Z; Wang J; Shang R; Zhou L; Wang X; Duan J; Ruan B; Gao Y; Dai B; Qu S; Liu W; Ding R; Wang L; Wang D; Dou K Oncotarget; 2016 Mar; 7(10):11595-608. PubMed ID: 26871477 [TBL] [Abstract][Full Text] [Related]
16. MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin pathway. Zhang JG; Shi Y; Hong DF; Song M; Huang D; Wang CY; Zhao G Sci Rep; 2015 Jan; 5():8087. PubMed ID: 25627001 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4. Zhao Y; Li F; Zhang X; Liu A; Qi J; Cui H; Zhao P Int J Clin Exp Pathol; 2015; 8(10):12446-54. PubMed ID: 26722431 [TBL] [Abstract][Full Text] [Related]
18. miR-493-5p suppresses hepatocellular carcinoma cell proliferation through targeting GP73. Zhao J; Xu T; Wang F; Cai W; Chen L Biomed Pharmacother; 2017 Jun; 90():744-751. PubMed ID: 28419971 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-133b inhibits hepatocellular carcinoma cell progression by targeting Sirt1. Tian Z; Jiang H; Liu Y; Huang Y; Xiong X; Wu H; Dai X Exp Cell Res; 2016 May; 343(2):135-147. PubMed ID: 27090017 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-519c-3p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting BTG3. Wang L; Mo H; Jiang Y; Wang Y; Sun L; Yao B; Chen T; Liu R; Li Q; Liu Q; Yin G Biomed Pharmacother; 2019 Oct; 118():109267. PubMed ID: 31387005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]